Also trades as: 4547.T (JPX) · $vol 2M

$24.50

-1.27 (-4.93%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 53 · $1.0B mcap · 24M float · 0.0004% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$98.0B +11.0% ▲

5Y CAGR: +7.3%

Gross Profit

$46.1B +4.6% ▲

5Y CAGR: +177.6%

Operating Income

-$2.9B -151.0% ▼

Net Income

$13.9B +15.9% ▲

5Y CAGR: +21.3%

EPS (Diluted)

$333.94 +21.8% ▲

5Y CAGR: +24.1%

EBITDA

$1.7B -91.5% ▼

5Y CAGR: -18.0%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$65.4B	$67.5B	$75.6B	$88.3B	$98.0B
YoY Growth	-5.3%	+3.2%	+12.0%	+16.9%	+11.0%
Cost of Revenue	$299M	$284M	$38.2B	$44.3B	$51.9B
Gross Profit	$238M	$224M	$37.3B	$44.1B	$46.1B
Gross Margin	0.4%	0.3%	49.4%	49.9%	47.0%
R&D Expenses	$10.4B	$10.4B	$0	$0	$0
SG&A Expenses	$19.9B	$20.3B	$0	$38.3B	$49.1B
Operating Expenses	$32.6B	$33.5B	$33.3B	$38.3B	$49.1B
Operating Income	-$1.4B	-$1.1B	$4.0B	$5.8B	-$2.9B
Operating Margin	-2.1%	-1.7%	5.3%	6.5%	-3.0%
Interest Expense	$23M	$20M	$18M	$21M	$28M
Income Before Tax	$16.5B	$13.7B	$14.4B	$15.6B	$17.0B
Tax Expense	$3.5B	$3.0B	$3.2B	$3.6B	$2.9B
Net Income	$12.9B	$10.5B	$11.2B	$12.0B	$13.9B
Net Margin	19.8%	15.6%	14.8%	13.5%	14.1%
EPS (Diluted)	$280.20	$228.31	$246.58	$274.21	$333.94
EBITDA	$2.3B	$3.0B	$18.7B	$20.2B	$1.7B
Shares Outstanding	46M	46M	45M	44M	42M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$21.2B	$21.3B	$23.2B	$22.7B	$22.2B	$24.0B	$26.8B	$24.9B
Cost of Revenue	$10.3B	$10.8B	$11.5B	$11.7B	$11.1B	$12.2B	$14.5B	$14.0B
Gross Profit	$10.9B	$10.5B	$11.7B	$10.9B	$11.1B	$11.8B	$12.3B	$10.9B
Gross Margin	51.4%	49.4%	50.5%	48.3%	49.9%	49.1%	45.9%	43.7%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$8.7B	$10.9B	$9.3B	$9.4B	$9.0B	$20.8B	$9.2B	$10.1B
Operating Expenses	$8.7B	$10.9B	$9.3B	$9.4B	$9.0B	$20.8B	$9.2B	$10.1B
Operating Income	$2.2B	-$377M	$2.5B	$1.5B	$2.1B	-$9.1B	$3.2B	$761M
Operating Margin	10.2%	-1.8%	10.6%	6.8%	9.5%	-37.8%	11.8%	3.1%
Interest Expense	$4M	$0	$0	$40K	$42K	$7M	$7M	$8M
Income Before Tax	$5.5B	$1.6B	$4.4B	$4.0B	$5.7B	$3.7B	$4.2B	$3.3B
Tax Expense	$1.4B	$491M	$811M	$916M	$1.2B	$309M	$917M	$485M
Net Income	$4.1B	$1.1B	$3.6B	$3.1B	$4.5B	$3.3B	$3.2B	$2.8B
Net Margin	19.4%	5.4%	15.5%	13.8%	20.4%	13.8%	12.1%	11.2%
EPS (Diluted)	$92.88	$25.86	$82.99	$72.91	$107.87	$80.00	$77.99	$67.11
EBITDA	$13.3B	$765M	$3.5B	$2.7B	$3.3B	$4.9B	$5.4B	$2.0B
Shares Outstanding	44M	44M	43M	43M	42M	41M	41M	41M

KSPHF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet